Selective stimulation of central alpha-autoreceptors following treatment with alpha-methyldopa and FLA 136
- PMID: 38408
- DOI: 10.1007/BF00507112
Selective stimulation of central alpha-autoreceptors following treatment with alpha-methyldopa and FLA 136
Abstract
1. The accumulation of normetanephrine in the rat brain induced by the monoamine oxidase inhibitor nialamide was inhibited following alpha-methyldopa and 4-amino-3-(2,6-dichlorobenzylidenehydrazino)-1,2,4-triazole (FLA 136). It was not changed following alpha-methylmetatyrosine despite a greater disappearance of noradrenaline than after alpha-methyldopa. The alpha-adrenoreceptor blocking agent yohimbine increased the nialamide-induced accumulation of normetanephrine and completely antagonized the actions of alpha-methyldopa and FLA 136, indicating that the effects of the two drugs are due to stimulation of alpha-adrenoreceptors. 2. The flexor reflex activity of spinalized rats was not influenced by alpha-methyldopa and alpha-methylmetatyrosine at the doses used in the biochemical experiments, as previously found for FLA 136, indicating no stimulation of classical, postsynaptic, central alpha-adrenoreceptors. 3. The biochemical effects of alpha-methyldopa and FLA 136 might be caused by stimulation of alpha-autoreceptors on the cell bodies and the nerve terminals of noradrenaline neurons. A similar mechanism might be involved in the hypotension reported by other investigators following these drugs.
Similar articles
-
Noradrenaline synthesis and utilization: control by nerve impulse flow under normal conditions and after treatment with alpha-adrenoreceptor blocking agents.Naunyn Schmiedebergs Arch Pharmacol. 1976;292(1):53-8. doi: 10.1007/BF00506489. Naunyn Schmiedebergs Arch Pharmacol. 1976. PMID: 6919
-
FLA 136: selective agonist at central alpha-adrenoreceptors mediating changes in the turnover of noradrenaline.Naunyn Schmiedebergs Arch Pharmacol. 1977 Jul;298(3):239-43. doi: 10.1007/BF00500894. Naunyn Schmiedebergs Arch Pharmacol. 1977. PMID: 19710 No abstract available.
-
Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents.Naunyn Schmiedebergs Arch Pharmacol. 1976;292(1):43-52. doi: 10.1007/BF00506488. Naunyn Schmiedebergs Arch Pharmacol. 1976. PMID: 6918
-
Cardiovascular regulation by central adrenergic mechanisms and its alteration by hypotensive drugs.Circ Res. 1975 Jun;36(6 Suppl 1):223-32. doi: 10.1161/01.res.36.6.223. Circ Res. 1975. PMID: 1093754 Review.
-
The hypotensive activity and side effects of methyldopa, clonidine, and guanfacine.Hypertension. 1984 Sep-Oct;6(5 Pt 2):II28-33. doi: 10.1161/01.hyp.6.5_pt_2.ii28. Hypertension. 1984. PMID: 6094346 Review.
Cited by
-
Synergistic interactions between muscarinic antagonists, adrenergic agonists and NMDA antagonists with respect to locomotor stimulatory effects in monoamine-depleted mice.Naunyn Schmiedebergs Arch Pharmacol. 1991 Jun;343(6):568-73. doi: 10.1007/BF00184286. Naunyn Schmiedebergs Arch Pharmacol. 1991. PMID: 1682816